{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:24:02Z","timestamp":1793834642521,"version":"4.6.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10917-1","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T15:51:46Z","timestamp":1754581906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Decoding NF-\u03baB: nucleocytoplasmic shuttling dynamics, synthetic modulation and post-therapeutic behavior in cancer"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2307-1907","authenticated-orcid":false,"given":"Ahmed S.","family":"Alhallaq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3850-0222","authenticated-orcid":false,"given":"Nadeen S.","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"10917_CR1","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1101\/gad.1228704","volume":"18","author":"MS Hayden","year":"2004","unstructured":"Hayden MS, Ghosh S (2004) Signaling to NF-\u03baB. Genes. Genes Dev 18:2195\u20132224. https:\/\/doi.org\/10.1101\/gad.1228704","journal-title":"Genes Dev"},{"key":"10917_CR2","doi-asserted-by":"publisher","first-page":"e589","DOI":"10.1371\/journal.pone.0000589","volume":"2","author":"I Mikenberg","year":"2007","unstructured":"Mikenberg I, Widera D, Kaus A et al (2007) Transcription factor NF-\u03baB is transported to the nucleus via cytoplasmic dynein\/dynactin motor complex in hippocampal neurons. PLoS ONE 2:e589. https:\/\/doi.org\/10.1371\/journal.pone.0000589","journal-title":"PLoS ONE"},{"key":"10917_CR3","doi-asserted-by":"publisher","first-page":"eaau3568","DOI":"10.1126\/scisignal.aau3568","volume":"12","author":"MM DeFelice","year":"2019","unstructured":"DeFelice MM, Clark HR, Hughey JJ et al (2019) NF-\u03baB signaling dynamics is controlled by a dose-sensing autoregulatory loop. Sci Signal 12:eaau3568. https:\/\/doi.org\/10.1126\/scisignal.aau3568","journal-title":"Sci Signal"},{"key":"10917_CR4","doi-asserted-by":"publisher","unstructured":"Shrum CK, DeFrancisco D, Meffert MK (2009) Stimulated nuclear translocation of NF-\u03baB and shuttling differentially depend on dynein and the dynactin complex. Proc Natl Acad Sci 106:2647\u20132652. https:\/\/doi.org\/10.1073\/pnas.0806677106","DOI":"10.1073\/pnas.0806677106"},{"key":"10917_CR5","doi-asserted-by":"publisher","first-page":"e0142296","DOI":"10.1371\/journal.pone.0142296","volume":"10","author":"J Zhu","year":"2015","unstructured":"Zhu J, Cynader MS, Jia W (2015) TDP-43 inhibits NF-\u03baB activity by blocking p65 nuclear translocation. PLoS ONE 10:e0142296. https:\/\/doi.org\/10.1371\/journal.pone.0142296","journal-title":"PLoS ONE"},{"key":"10917_CR6","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cels.2017.09.016","volume":"5","author":"Z-B Zhang","year":"2017","unstructured":"Zhang Z-B, Wang Q-Y, Ke Y-X et al (2017) Design of tunable oscillatory dynamics in a synthetic NF-\u03baB signaling circuit. Cell Syst 5:460\u2013470e5. https:\/\/doi.org\/10.1016\/j.cels.2017.09.016","journal-title":"Cell Syst"},{"key":"10917_CR7","doi-asserted-by":"publisher","first-page":"2000147","DOI":"10.1002\/adbi.202000147","volume":"5","author":"P Tan","year":"2021","unstructured":"Tan P, He L, Zhou Y (2021) Engineering supramolecular organizing centers for optogenetic control of innate immune responses. Adv Biol 5:2000147. https:\/\/doi.org\/10.1002\/adbi.202000147","journal-title":"Adv Biol"},{"key":"10917_CR8","doi-asserted-by":"publisher","first-page":"764164","DOI":"10.3389\/fcell.2021.764164","volume":"9","author":"G Ghosh","year":"2021","unstructured":"Ghosh G, Wang VY-F (2021) Origin of the functional distinctiveness of NF-\u03baB\/p52. Front Cell Dev Biol 9:764164. https:\/\/doi.org\/10.3389\/fcell.2021.764164","journal-title":"Front Cell Dev Biol"},{"key":"10917_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/cr.2010.171","volume":"21","author":"C Zheng","year":"2011","unstructured":"Zheng C, Yin Q, Wu H (2011) Structural studies of NF-\u03baB signaling. Cell Res 21:183\u2013195. https:\/\/doi.org\/10.1038\/cr.2010.171","journal-title":"Cell Res"},{"key":"10917_CR10","doi-asserted-by":"publisher","first-page":"e86258","DOI":"10.7554\/eLife.86258","volume":"12","author":"W Pan","year":"2023","unstructured":"Pan W, Meshcheryakov VA, Li T et al (2023) Structures of NF-\u03baB p52 homodimer-DNA complexes rationalize binding mechanisms and transcription activation. Elife 12:e86258. https:\/\/doi.org\/10.7554\/eLife.86258","journal-title":"Elife"},{"key":"10917_CR11","doi-asserted-by":"publisher","first-page":"a000216","DOI":"10.1101\/cshperspect.a000216","volume":"2","author":"E O\u2019Dea","year":"2010","unstructured":"O\u2019Dea E, Hoffmann A (2010) The regulatory logic of the NF- B signaling system. Cold Spring Harb Perspect Biol 2:a000216\u2013a000216. https:\/\/doi.org\/10.1101\/cshperspect.a000216","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10917_CR12","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3389\/fimmu.2020.01387","volume":"11","author":"C Peng","year":"2020","unstructured":"Peng C, Ouyang Y, Lu N, Li N (2020) The NF-\u03baB signaling pathway, the microbiota, and Gastrointestinal tumorigenesis: recent advances. Front Immunol 11:1387. https:\/\/doi.org\/10.3389\/fimmu.2020.01387","journal-title":"Front Immunol"},{"key":"10917_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.molcel.2012.04.020","volume":"47","author":"B Schr\u00f6felbauer","year":"2012","unstructured":"Schr\u00f6felbauer B, Polley S, Behar M et al (2012) NEMO ensures signaling specificity of the pleiotropic IKK\u03b2 by directing its kinase activity toward I\u03baB\u03b1. Mol Cell 47:111\u2013121. https:\/\/doi.org\/10.1016\/j.molcel.2012.04.020","journal-title":"Mol Cell"},{"key":"10917_CR14","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/ni.2446","volume":"13","author":"VF-S Shih","year":"2012","unstructured":"Shih VF-S, Davis-Turak J, Macal M et al (2012) Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-\u03baB pathways. Nat Immunol 13:1162\u20131170. https:\/\/doi.org\/10.1038\/ni.2446","journal-title":"Nat Immunol"},{"key":"10917_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri.2017.52","volume":"17","author":"S-C Sun","year":"2017","unstructured":"Sun S-C (2017) The non-canonical NF-\u03baB pathway in immunity and inflammation. Nat Rev Immunol 17:545\u2013558. https:\/\/doi.org\/10.1038\/nri.2017.52","journal-title":"Nat Rev Immunol"},{"key":"10917_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu H, Lin L, Zhang Z et al (2020) Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther 5:209. https:\/\/doi.org\/10.1038\/s41392-020-00312-6","journal-title":"Signal Transduct Target Ther"},{"key":"10917_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1600-065X.2011.01059.x","volume":"244","author":"B Razani","year":"2011","unstructured":"Razani B, Reichardt AD, Cheng G (2011) Non-canonical NF\u2010\u03baB signaling activation and regulation: principles and perspectives. Immunol Rev 244:44\u201354. https:\/\/doi.org\/10.1111\/j.1600-065X.2011.01059.x","journal-title":"Immunol Rev"},{"key":"10917_CR18","doi-asserted-by":"publisher","first-page":"ra96","DOI":"10.1126\/scisignal.aad9413","volume":"9","author":"AJ Fusco","year":"2016","unstructured":"Fusco AJ, Mazumder A, Wang VY-F et al (2016) The NF-\u03baB subunit RelB controls p100 processing by competing with the kinases NIK and IKK1 for binding to p100. Sci Signal 9:ra96\u2013ra96. https:\/\/doi.org\/10.1126\/scisignal.aad9413","journal-title":"Sci Signal"},{"key":"10917_CR19","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1101\/gad.1680708","volume":"22","author":"SL Werner","year":"2008","unstructured":"Werner SL, Kearns JD, Zadorozhnaya V et al (2008) Encoding NF-\u03baB Temporal control in response to TNF: distinct roles for the negative regulators I\u03baB\u03b1 and A20. Genes Dev 22:2093\u20132101. https:\/\/doi.org\/10.1101\/gad.1680708","journal-title":"Genes Dev"},{"key":"10917_CR20","doi-asserted-by":"publisher","first-page":"16096","DOI":"10.1074\/jbc.M109.072694","volume":"285","author":"C Li","year":"2010","unstructured":"Li C, Chen S, Yue P et al (2010) Proteasome inhibitor PS-341 (Bortezomib) induces Calpain-dependent I\u03baB\u03b1 degradation. J Biol Chem 285:16096\u201316104. https:\/\/doi.org\/10.1074\/jbc.M109.072694","journal-title":"J Biol Chem"},{"key":"10917_CR21","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/mol.65.2.342","volume":"65","author":"ZH N\u00e9meth","year":"2004","unstructured":"N\u00e9meth ZH, Wong HR, Odoms K et al (2004) Proteasome inhibitors induce inhibitory \u03baB (I\u03baB) kinase activation, I\u03baB\u03b1 degradation, and nuclear factor \u03baB activation in HT-29 cells. Mol Pharmacol 65:342\u2013349. https:\/\/doi.org\/10.1124\/mol.65.2.342","journal-title":"Mol Pharmacol"},{"key":"10917_CR22","doi-asserted-by":"publisher","first-page":"107804","DOI":"10.1016\/j.intimp.2021.107804","volume":"97","author":"T Pu","year":"2021","unstructured":"Pu T, Liu W, Wu Y, Zhao Y (2021) A20 functions as a negative regulator in macrophage for DSS-induced colitis. Int Immunopharmacol 97:107804. https:\/\/doi.org\/10.1016\/j.intimp.2021.107804","journal-title":"Int Immunopharmacol"},{"key":"10917_CR23","doi-asserted-by":"publisher","unstructured":"V Harper C, Woodcock DJ, Lam C et al (2018) Temperature regulates NF-\u03baB dynamics and function through timing of A20 transcription. Proc Natl Acad Sci 115(E5243\u2013E5249). https:\/\/doi.org\/10.1073\/pnas.1803609115","DOI":"10.1073\/pnas.1803609115"},{"key":"10917_CR24","doi-asserted-by":"publisher","unstructured":"Lee EG, Boone DL, Chai S et al (2000) Failure to Regulate TNF-Induced NF-\u03baB and Cell Death Responses in A20-Deficient Mice. Science (1979) 289:2350\u20132354. https:\/\/doi.org\/10.1126\/science.289.5488.2350","DOI":"10.1126\/science.289.5488.2350"},{"key":"10917_CR25","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1038\/s12276-023-01133-7","volume":"55","author":"M Son","year":"2023","unstructured":"Son M, Wang AG, Keisham B, Tay S (2023) Processing stimulus dynamics by the NF-\u03baB network in single cells. Exp Mol Med 55:2531\u20132540. https:\/\/doi.org\/10.1038\/s12276-023-01133-7","journal-title":"Exp Mol Med"},{"key":"10917_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X et al (2024) NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther 9:53. https:\/\/doi.org\/10.1038\/s41392-024-01757-9","journal-title":"Signal Transduct Target Ther"},{"key":"10917_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01310-w","author":"H Mao","year":"2025","unstructured":"Mao H, Zhao X, Sun S (2025) NF-\u03baB in inflammation and cancer. Cell Mol Immunol. https:\/\/doi.org\/10.1038\/s41423-025-01310-w","journal-title":"Cell Mol Immunol"},{"key":"10917_CR28","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/mco2.104","volume":"2","author":"T Zhang","year":"2021","unstructured":"Zhang T, Ma C, Zhang Z et al (2021) NF-\u03baB signaling in inflammation and cancer. MedComm (Beijing) 2:618\u2013653. https:\/\/doi.org\/10.1002\/mco2.104","journal-title":"MedComm (Beijing)"},{"key":"10917_CR29","doi-asserted-by":"publisher","first-page":"1476030","DOI":"10.3389\/fimmu.2024.1476030","volume":"15","author":"Y Cao","year":"2024","unstructured":"Cao Y, Yi Y, Han C, Shi B (2024) NF-\u03baB signaling pathway in tumor microenvironment. Front Immunol 15:1476030. https:\/\/doi.org\/10.3389\/fimmu.2024.1476030","journal-title":"Front Immunol"},{"key":"10917_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/cr.2011.13","volume":"21","author":"MS Hayden","year":"2011","unstructured":"Hayden MS, Ghosh S (2011) NF-\u03baB in immunobiology. Cell Res 21:223\u2013244. https:\/\/doi.org\/10.1038\/cr.2011.13","journal-title":"Cell Res"},{"key":"10917_CR31","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jaci.2020.07.027","volume":"146","author":"M Kracht","year":"2020","unstructured":"Kracht M, M\u00fcller-Ladner U, Schmitz ML (2020) Mutual regulation of metabolic processes and Proinflammatory NF-\u03baB signaling. J Allergy Clin Immunol 146:694\u2013705. https:\/\/doi.org\/10.1016\/j.jaci.2020.07.027","journal-title":"J Allergy Clin Immunol"},{"key":"10917_CR32","doi-asserted-by":"publisher","first-page":"6804","DOI":"10.1074\/jbc.274.10.6804","volume":"274","author":"P Turpin","year":"1999","unstructured":"Turpin P, Hay RT, Dargemont C (1999) Characterization of I\u03baB\u03b1 nuclear import pathway. J Biol Chem 274:6804\u20136812. https:\/\/doi.org\/10.1074\/jbc.274.10.6804","journal-title":"J Biol Chem"},{"key":"10917_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13062-016-0164-z","volume":"11","author":"Z Korwek","year":"2016","unstructured":"Korwek Z, Tudelska K, Na\u0142\u0119cz-Jawecki P et al (2016) Importins promote high-frequency NF-\u03baB oscillations increasing information channel capacity. Biol Direct 11:61. https:\/\/doi.org\/10.1186\/s13062-016-0164-z","journal-title":"Biol Direct"},{"key":"10917_CR34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/genes13010128","volume":"13","author":"M-Y Zhang","year":"2022","unstructured":"Zhang M-Y, Calin G, Deng M-D et al (2022) Epigenetic Silencing of tumor suppressor LncRNA NKILA: implication on NF-\u03baB signaling in Non-Hodgkin\u2019s lymphoma. Genes (Basel) 13:128. https:\/\/doi.org\/10.3390\/genes13010128","journal-title":"Genes (Basel)"},{"key":"10917_CR35","doi-asserted-by":"publisher","first-page":"67626","DOI":"10.18632\/oncotarget.18795","volume":"8","author":"SM Egan","year":"2017","unstructured":"Egan SM, Karasik E, Ellis L, Gollnick SO (2017) miR-30e* is overexpressed in prostate cancer and promotes NF-\u03baB-mediated proliferation and tumor growth. Oncotarget 8:67626\u201367638. https:\/\/doi.org\/10.18632\/oncotarget.18795","journal-title":"Oncotarget"},{"key":"10917_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1172\/JCI58849","volume":"122","author":"L Jiang","year":"2012","unstructured":"Jiang L, Lin C, Song L et al (2012) MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-\u03baB\/I\u03baB\u03b1 negative feedback loop. J Clin Invest 122:33\u201347. https:\/\/doi.org\/10.1172\/JCI58849","journal-title":"J Clin Invest"},{"key":"10917_CR37","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1158\/0008-5472.CAN-15-1770","volume":"76","author":"L Jiang","year":"2016","unstructured":"Jiang L, Yu L, Zhang X et al (2016) miR-892b Silencing activates NF-\u03baB and promotes aggressiveness in breast cancer. Cancer Res 76:1101\u20131111. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1770","journal-title":"Cancer Res"},{"key":"10917_CR38","doi-asserted-by":"publisher","unstructured":"Wong PMC, Chung S-W (2003) A Functional Connection between RanGTP, NF-\u03baB and Septic Shock. J Biomed Sci 10:468\u2013474. https:\/\/doi.org\/10.1159\/000072374","DOI":"10.1159\/000072374"},{"key":"10917_CR39","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.161513","author":"Z-H Deng","year":"2014","unstructured":"Deng Z-H, Gomez TS, Osborne DG et al (2014) Nuclear localized FAM21 participates in NF-\u03baB-dependent gene regulation in pancreatic cancer cells. J Cell Sci. https:\/\/doi.org\/10.1242\/jcs.161513","journal-title":"J Cell Sci"},{"key":"10917_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3389\/fcell.2020.00429","volume":"8","author":"C Wang","year":"2020","unstructured":"Wang C, Chen Y, Chen K, Zhang L (2020) Long noncoding RNA LINC01134 promotes hepatocellular carcinoma metastasis via activating AKT1S1 and NF-\u03baB signaling. Front Cell Dev Biol 8:429. https:\/\/doi.org\/10.3389\/fcell.2020.00429","journal-title":"Front Cell Dev Biol"},{"key":"10917_CR41","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1080\/15476286.2022.2027149","volume":"19","author":"W Zhao","year":"2022","unstructured":"Zhao W, Xin L, Tang L et al (2022) A positive feedback loop between LINC01605 and NF-\u03baB pathway promotes tumor growth in nasopharyngeal carcinoma. RNA Biol 19:482\u2013495. https:\/\/doi.org\/10.1080\/15476286.2022.2027149","journal-title":"RNA Biol"},{"key":"10917_CR42","doi-asserted-by":"publisher","first-page":"48547","DOI":"10.18632\/oncotarget.10423","volume":"7","author":"X Cui","year":"2016","unstructured":"Cui X, Kong C, Zhu Y et al (2016) miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-\u03baB and sustains NF-\u03baB activation by decreasing cylindromatosis expression. Oncotarget 7:48547\u201348561. https:\/\/doi.org\/10.18632\/oncotarget.10423","journal-title":"Oncotarget"},{"key":"10917_CR43","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1172\/JCI62339","volume":"122","author":"L Song","year":"2012","unstructured":"Song L, Liu L, Wu Z et al (2012) TGF-\u03b2 induces miR-182 to sustain NF-\u03baB activation in glioma subsets. J Clin Invest 122:3563\u20133578. https:\/\/doi.org\/10.1172\/JCI62339","journal-title":"J Clin Invest"},{"key":"10917_CR44","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1158\/0008-5472.CAN-15-1022","volume":"75","author":"T Lu","year":"2015","unstructured":"Lu T, Stark GR (2015) NF-\u03baB: regulation by methylation. Cancer Res 75:3692\u20133695. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1022","journal-title":"Cancer Res"},{"key":"10917_CR45","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1158\/1535-7163.MCT-08-0238","volume":"7","author":"Y Xu","year":"2008","unstructured":"Xu Y, Fang F, St. Clair DK et al (2008) SN52, a novel nuclear factor-\u03baB inhibitor, blocks nuclear import of RelB:p52 dimer and sensitizes prostate cancer cells to ionizing radiation. Mol Cancer Ther 7:2367\u20132376. https:\/\/doi.org\/10.1158\/1535-7163.MCT-08-0238","journal-title":"Mol Cancer Ther"},{"key":"10917_CR46","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1038\/s41467-024-46728-4","volume":"15","author":"DA Ang","year":"2024","unstructured":"Ang DA, Carter J-M, Deka K et al (2024) Aberrant non-canonical NF-\u03baB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma. Nat Commun 15:2513. https:\/\/doi.org\/10.1038\/s41467-024-46728-4","journal-title":"Nat Commun"},{"key":"10917_CR47","doi-asserted-by":"publisher","first-page":"ra13","DOI":"10.1126\/scisignal.2004557","volume":"7","author":"CM Gray","year":"2014","unstructured":"Gray CM, Remouchamps C, McCorkell KA et al (2014) Noncanonical NF-\u03baB signaling is limited by classical NF-\u03baB activity. Sci Signal 7:ra13\u2013ra13. https:\/\/doi.org\/10.1126\/scisignal.2004557","journal-title":"Sci Signal"},{"key":"10917_CR48","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1080\/15384101.2014.998067","volume":"14","author":"MY Murray","year":"2015","unstructured":"Murray MY, Zaitseva L, Auger MJ et al (2015) Ibrutinib inhibits BTK-driven NF-\u03baB p65 activity to overcome bortezomib-resistance in multiple myeloma. Cell Cycle 14:2367\u20132375. https:\/\/doi.org\/10.1080\/15384101.2014.998067","journal-title":"Cell Cycle"},{"key":"10917_CR49","first-page":"3280","volume":"12","author":"T Kubicki","year":"2022","unstructured":"Kubicki T, Bednarek K, Kostrzewska-Poczekaj M et al (2022) Bortezomib- and carfilzomib-resistant myeloma cells show increased activity of all three arms of the unfolded protein response. Am J Cancer Res 12:3280\u20133293","journal-title":"Am J Cancer Res"},{"key":"10917_CR50","doi-asserted-by":"publisher","unstructured":"Fischer AAM, Grimm MM, Fliegauf M et al (2024) Activation of NF-\u03baB signaling by optogenetic clustering of IKK\u03b1 and \u03b2. https:\/\/doi.org\/10.1101\/2024.06.12.598631. bioRxiv 2024-06","DOI":"10.1101\/2024.06.12.598631"},{"key":"10917_CR51","doi-asserted-by":"publisher","first-page":"22625","DOI":"10.1021\/acsomega.4c00049","volume":"9","author":"P Gautam","year":"2024","unstructured":"Gautam P, Sinha SK (2024) The blueprint of logical decisions in a NF-\u03baB signaling system. ACS Omega 9:22625\u201322634. https:\/\/doi.org\/10.1021\/acsomega.4c00049","journal-title":"ACS Omega"},{"key":"10917_CR52","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.3390\/ijms22179232","volume":"22","author":"A Stierschneider","year":"2021","unstructured":"Stierschneider A, Gr\u00fcnst\u00e4udl P, Colleselli K et al (2021) Light-Inducible Spatio-Temporal control of TLR4 and NF-\u03baB-Gluc reporter in human pancreatic cell line. Int J Mol Sci 22:9232. https:\/\/doi.org\/10.3390\/ijms22179232","journal-title":"Int J Mol Sci"},{"key":"10917_CR53","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cell.2019.01.039","volume":"177","author":"Y Tan","year":"2019","unstructured":"Tan Y, Kagan JC (2019) Innate immune signaling organelles display natural and programmable signaling flexibility. Cell 177:384\u2013398. https:\/\/doi.org\/10.1016\/j.cell.2019.01.039..e11","journal-title":"Cell"},{"key":"10917_CR54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12918-018-0525-6","volume":"12","author":"Z Wang","year":"2018","unstructured":"Wang Z, Potoyan DA, Wolynes PG (2018) Modeling the therapeutic efficacy of NF\u03baB synthetic decoy oligodeoxynucleotides (ODNs). BMC Syst Biol 12:4. https:\/\/doi.org\/10.1186\/s12918-018-0525-6","journal-title":"BMC Syst Biol"},{"key":"10917_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13036-025-00519-7","volume":"19","author":"A Cimino","year":"2025","unstructured":"Cimino A, Pat F, Oyebamiji O et al (2025) Dual-responsive synthetic gene circuit for dynamic biologic drug delivery via inflammatory and circadian signaling pathways. J Biol Eng 19:47. https:\/\/doi.org\/10.1186\/s13036-025-00519-7","journal-title":"J Biol Eng"},{"key":"10917_CR56","doi-asserted-by":"publisher","first-page":"e09100","DOI":"10.7554\/eLife.09100","volume":"5","author":"S Zambrano","year":"2016","unstructured":"Zambrano S, De Toma I, Piffer A et al (2016) NF-\u03baB oscillations translate into functionally related patterns of gene expression. Elife 5:e09100. https:\/\/doi.org\/10.7554\/eLife.09100","journal-title":"Elife"},{"key":"10917_CR57","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.abb.2008.04.026","volume":"475","author":"H-Y Vu","year":"2008","unstructured":"Vu H-Y, Juvekar A, Ghosh C et al (2008) Proteasome inhibitors induce apoptosis of prostate cancer cells by inducing nuclear translocation of I\u03baB\u03b1. Arch Biochem Biophys 475:156\u2013163. https:\/\/doi.org\/10.1016\/j.abb.2008.04.026","journal-title":"Arch Biochem Biophys"},{"key":"10917_CR58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/biomedicines9010033","volume":"9","author":"M Tsubaki","year":"2021","unstructured":"Tsubaki M, Takeda T, Matsuda T et al (2021) Activation of serum\/glucocorticoid regulated kinase 1\/nuclear Factor-\u03baB pathway are correlated with low sensitivity to bortezomib and Ixazomib in resistant multiple myeloma cells. Biomedicines 9:33. https:\/\/doi.org\/10.3390\/biomedicines9010033","journal-title":"Biomedicines"},{"key":"10917_CR59","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1158\/1078-0432.CCR-12-0779","volume":"18","author":"C Fabre","year":"2012","unstructured":"Fabre C, Mimura N, Bobb K et al (2012) Dual Inhibition of canonical and noncanonical NF-\u03baB pathways demonstrates significant antitumor activities in multiple myeloma. Clin Cancer Res 18:4669\u20134681. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0779","journal-title":"Clin Cancer Res"},{"key":"10917_CR60","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1002\/jcp.24955","volume":"230","author":"W Chou","year":"2015","unstructured":"Chou W, Chuang K, Sun D et al (2015) Inhibition of PKC-Induced COX\u20102 and IL\u20108 expression in human breast cancer cells by glucosamine. J Cell Physiol 230:2240\u20132251. https:\/\/doi.org\/10.1002\/jcp.24955","journal-title":"J Cell Physiol"},{"key":"10917_CR61","doi-asserted-by":"publisher","first-page":"24233","DOI":"10.1074\/jbc.M212389200","volume":"278","author":"Y Takada","year":"2003","unstructured":"Takada Y, Mukhopadhyay A, Kundu GC et al (2003) Hydrogen peroxide activates NF-\u03baB through tyrosine phosphorylation of I\u03baB\u03b1 and Serine phosphorylation of p65. J Biol Chem 278:24233\u201324241. https:\/\/doi.org\/10.1074\/jbc.M212389200","journal-title":"J Biol Chem"},{"key":"10917_CR62","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1097\/MIB.0000000000000471","volume":"21","author":"AH Rose","year":"2015","unstructured":"Rose AH, Huang Z, Mafnas C et al (2015) Calpain-2 inhibitor therapy reduces murine colitis and colitis-associated cancer. Inflamm Bowel Dis 21:2005\u20132015. https:\/\/doi.org\/10.1097\/MIB.0000000000000471","journal-title":"Inflamm Bowel Dis"},{"key":"10917_CR63","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.7150\/ijbs.26776","volume":"14","author":"X Li","year":"2018","unstructured":"Li X, Liang M, Jiang J et al (2018) Combined Inhibition of autophagy and Nrf2 signaling augments bortezomib-induced apoptosis by increasing ROS production and ER stress in pancreatic cancer cells. Int J Biol Sci 14:1291\u20131305. https:\/\/doi.org\/10.7150\/ijbs.26776","journal-title":"Int J Biol Sci"},{"key":"10917_CR64","doi-asserted-by":"publisher","first-page":"e32584","DOI":"10.1371\/journal.pone.0032584","volume":"7","author":"L Jia","year":"2012","unstructured":"Jia L, Gopinathan G, Sukumar JT, Gribben JG (2012) Blocking autophagy prevents Bortezomib-Induced NF-\u03baB activation by reducing I-\u03baB\u03b1 degradation in lymphoma cells. PLoS ONE 7:e32584. https:\/\/doi.org\/10.1371\/journal.pone.0032584","journal-title":"PLoS ONE"},{"key":"10917_CR65","doi-asserted-by":"publisher","first-page":"107455","DOI":"10.1016\/j.leukres.2024.107455","volume":"138","author":"R Zhang","year":"2024","unstructured":"Zhang R, Yang X, Shi X et al (2024) Bortezomib modulated the autophagy-lysosomal pathway in a TFEB-dependent manner in multiple myeloma. Leuk Res 138:107455. https:\/\/doi.org\/10.1016\/j.leukres.2024.107455","journal-title":"Leuk Res"},{"key":"10917_CR66","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bcp.2011.10.009","volume":"83","author":"LHAM de Wilt","year":"2012","unstructured":"de Wilt LHAM, Jansen G, Assaraf YG et al (2012) Proteasome-based mechanisms of intrinsic and acquired bortezomib resistance in non-small cell lung cancer. Biochem Pharmacol 83:207\u2013217. https:\/\/doi.org\/10.1016\/j.bcp.2011.10.009","journal-title":"Biochem Pharmacol"},{"key":"10917_CR67","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/cimb47050352","volume":"47","author":"G Kalampounias","year":"2025","unstructured":"Kalampounias G, Zafeiropoulou K, Androutsopoulou T et al (2025) The transcription axes ERK-Elk1, JNK-cJun, and JAK-STAT promote autophagy activation and proteasome inhibitor resistance in prostate cancer cells. Curr Issues Mol Biol 47:352. https:\/\/doi.org\/10.3390\/cimb47050352","journal-title":"Curr Issues Mol Biol"},{"key":"10917_CR68","doi-asserted-by":"publisher","first-page":"114698","DOI":"10.18632\/oncotarget.22815","volume":"8","author":"AIP Eug\u00eanio","year":"2017","unstructured":"Eug\u00eanio AIP, Fook-Alves VL, de Oliveira MB et al (2017) Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myeloma. Oncotarget 8:114698\u2013114709. https:\/\/doi.org\/10.18632\/oncotarget.22815","journal-title":"Oncotarget"},{"key":"10917_CR69","doi-asserted-by":"publisher","first-page":"111428","DOI":"10.1016\/j.celrep.2022.111428","volume":"40","author":"M Oro\u0144","year":"2022","unstructured":"Oro\u0144 M, Grochowski M, Jaiswar A et al (2022) The molecular network of the proteasome machinery Inhibition response is orchestrated by HSP70, revealing vulnerabilities in cancer cells. Cell Rep 40:111428. https:\/\/doi.org\/10.1016\/j.celrep.2022.111428","journal-title":"Cell Rep"},{"key":"10917_CR70","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12192-020-01078-0","volume":"25","author":"L Huang","year":"2020","unstructured":"Huang L, Wang Y, Bai J et al (2020) Blockade of HSP70 by VER-155008 synergistically enhances bortezomib-induced cytotoxicity in multiple myeloma. Cell Stress Chaperones 25:357\u2013367. https:\/\/doi.org\/10.1007\/s12192-020-01078-0","journal-title":"Cell Stress Chaperones"},{"key":"10917_CR71","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.18632\/oncotarget.3075","volume":"6","author":"MAY Abdel Malek","year":"2015","unstructured":"Abdel Malek MAY, Jagannathan S, Malek E et al (2015) Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma. Oncotarget 6:3098\u20133110. https:\/\/doi.org\/10.18632\/oncotarget.3075","journal-title":"Oncotarget"},{"key":"10917_CR72","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molimm.2025.05.001","volume":"183","author":"J Wang","year":"2025","unstructured":"Wang J, Jia H, Lv S et al (2025) Knockdown of RRBP1 regulates Endoplasmic reticulum stress to mitigate malignant progression and suppress bortezomib resistance of multiple myeloma cells by inhibiting GRP78 expression. Mol Immunol 183:72\u201382. https:\/\/doi.org\/10.1016\/j.molimm.2025.05.001","journal-title":"Mol Immunol"},{"key":"10917_CR73","doi-asserted-by":"publisher","unstructured":"Gigan JP, Garcia-Gonzalez P, Galliot L et al (2024) Single-Nuclei analysis of the unfolded protein response (SNUPR) reveals bortezomib resistance mechanisms in multiple myeloma. https:\/\/doi.org\/10.1101\/2024.10.22.617161. bioRxiv, 2024-10","DOI":"10.1101\/2024.10.22.617161"},{"key":"10917_CR74","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1182\/blood-2009-01-199604","volume":"114","author":"T Hideshima","year":"2009","unstructured":"Hideshima T, Ikeda H, Chauhan D et al (2009) Bortezomib induces canonical nuclear factor-\u03baB activation in multiple myeloma cells. Blood 114:1046\u20131052. https:\/\/doi.org\/10.1182\/blood-2009-01-199604","journal-title":"Blood"},{"key":"10917_CR75","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12032-021-01563-1","volume":"38","author":"E Kanbur","year":"2021","unstructured":"Kanbur E, Baykal AT, Yerlikaya A (2021) Molecular analysis of cell survival and death pathways in the proteasome inhibitor bortezomib-resistant PC3 prostate cancer cell line. Med Oncol 38:112. https:\/\/doi.org\/10.1007\/s12032-021-01563-1","journal-title":"Med Oncol"},{"key":"10917_CR76","doi-asserted-by":"publisher","first-page":"12358","DOI":"10.18632\/oncotarget.2590","volume":"5","author":"S Jaganathan","year":"2014","unstructured":"Jaganathan S, Malek E, Vallabhapurapu S et al (2014) Bortezomib induces AMPK-dependent autophagosome formation uncoupled from apoptosis in drug resistant cells. Oncotarget 5:12358\u201312370. https:\/\/doi.org\/10.18632\/oncotarget.2590","journal-title":"Oncotarget"},{"key":"10917_CR77","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1182\/blood.V110.11.3465.3465","volume":"110","author":"DT Yang","year":"2007","unstructured":"Yang DT, Young KH, Kahl BS, Miyamoto S (2007) Bortezomib resistant constitutive NF-\u03baB activation in mantle cell lymphoma. Blood 110:3465\u20133465. https:\/\/doi.org\/10.1182\/blood.V110.11.3465.3465","journal-title":"Blood"},{"key":"10917_CR78","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.3390\/cells10123464","volume":"10","author":"N Nikesitch","year":"2021","unstructured":"Nikesitch N, Rebeiro P, Ho LL et al (2021) The role of Chaperone-Mediated autophagy in bortezomib resistant multiple myeloma. Cells 10:3464. https:\/\/doi.org\/10.3390\/cells10123464","journal-title":"Cells"},{"key":"10917_CR79","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.3390\/cancers15194736","volume":"15","author":"EA Mulligan","year":"2023","unstructured":"Mulligan EA, Tudhope SJ, Hunter JE et al (2023) Expression and activity of the NF-\u03baB subunits in chronic lymphocytic leukaemia: A role for RelB and Non-Canonical signalling. Cancers (Basel) 15:4736. https:\/\/doi.org\/10.3390\/cancers15194736","journal-title":"Cancers (Basel)"},{"key":"10917_CR80","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.3390\/cancers14061489","volume":"14","author":"TA Burley","year":"2022","unstructured":"Burley TA, Kennedy E, Broad G et al (2022) Targeting the Non-Canonical NF-\u03baB pathway in chronic lymphocytic leukemia and multiple myeloma. Cancers (Basel) 14:1489. https:\/\/doi.org\/10.3390\/cancers14061489","journal-title":"Cancers (Basel)"},{"key":"10917_CR81","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3324\/haematol.2019.238584","volume":"106","author":"DB Thomas Lewis","year":"2020","unstructured":"Thomas Lewis DB, Corcoran DE, Thurston et al (2020) Novel pyrrolobenzodiazepine benzofused hybrid molecules inhibit NF-\u03baB activity and synergise with bortezomib and ibrutinib in hematological cancers. Haematologica 106:958\u2013967. https:\/\/doi.org\/10.3324\/haematol.2019.238584","journal-title":"Haematologica"},{"key":"10917_CR82","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.3390\/cancers14143557","volume":"14","author":"B Di Francesco","year":"2022","unstructured":"Di Francesco B, Verzella D, Capece D et al (2022) NF-\u03baB: A druggable target in acute myeloid leukemia. Cancers (Basel) 14:3557. https:\/\/doi.org\/10.3390\/cancers14143557","journal-title":"Cancers (Basel)"},{"key":"10917_CR83","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1365-2141.2011.08591.x","volume":"153","author":"Y Dai","year":"2011","unstructured":"Dai Y, Chen S, Wang L et al (2011) Bortezomib interacts synergistically with Belinostat in human acute myeloid leukaemia and acute lymphoblastic leukaemia cells in association with perturbations in NF-\u03baB and Bim. Br J Haematol 153:222\u2013235. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08591.x","journal-title":"Br J Haematol"},{"key":"10917_CR84","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1038\/s41418-020-00692-w","volume":"28","author":"M Haselager","year":"2021","unstructured":"Haselager M, Thijssen R, West C et al (2021) Regulation of Bcl-XL by non-canonical NF-\u03baB in the context of CD40-induced drug resistance in CLL. Cell Death Differ 28:1658\u20131668. https:\/\/doi.org\/10.1038\/s41418-020-00692-w","journal-title":"Cell Death Differ"},{"key":"10917_CR85","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.1182\/blood-2008-05-156422","volume":"113","author":"J Zhou","year":"2009","unstructured":"Zhou J, Bi C, Janakakumara JV et al (2009) Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML. Blood 113:4052\u20134062. https:\/\/doi.org\/10.1182\/blood-2008-05-156422","journal-title":"Blood"},{"key":"10917_CR86","doi-asserted-by":"publisher","unstructured":"Xia M, David L, Teater M et al (2022) BCL10 mutations define distinct dependencies guiding precision therapy for DLBCL. Cancer discov OF1\u2013OF20. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1566","DOI":"10.1158\/2159-8290.CD-21-1566"},{"key":"10917_CR87","doi-asserted-by":"publisher","first-page":"e75280","DOI":"10.1371\/journal.pone.0075280","volume":"8","author":"S Manni","year":"2013","unstructured":"Manni S, Brancalion A, Mandato E et al (2013) Protein kinase CK2 Inhibition down modulates the NF-\u03baB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells. PLoS ONE 8:e75280. https:\/\/doi.org\/10.1371\/journal.pone.0075280","journal-title":"PLoS ONE"},{"key":"10917_CR88","doi-asserted-by":"publisher","first-page":"2100072","DOI":"10.1002\/prca.202100072","volume":"16","author":"AD van Dijk","year":"2022","unstructured":"van Dijk AD, Hoff FW, Qiu Y et al (2022) Bortezomib is significantly beneficial for de Novo pediatric AML patients with low phosphorylation of the NF-\u03baB subunit rela. Proteom Clin Appl 16:2100072. https:\/\/doi.org\/10.1002\/prca.202100072","journal-title":"Proteom Clin Appl"},{"key":"10917_CR89","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.4049\/jimmunol.1300895","volume":"191","author":"S Manna","year":"2013","unstructured":"Manna S, Singha B, Phyo SA et al (2013) Proteasome Inhibition by bortezomib increases IL-8 expression in Androgen-Independent prostate cancer cells: the role of IKK\u03b1. J Immunol 191:2837\u20132846. https:\/\/doi.org\/10.4049\/jimmunol.1300895","journal-title":"J Immunol"},{"key":"10917_CR90","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3892\/ijo.2014.2273","volume":"44","author":"H HIDESHIMA","year":"2014","unstructured":"Hideshima H, Yoshida Y, Ikeda H et al (2014) IKK\u03b2 inhibitor in combination with bortezomib induces cytotoxicity in breast cancer cells. Int J Oncol 44:1171\u20131176. https:\/\/doi.org\/10.3892\/ijo.2014.2273","journal-title":"Int J Oncol"},{"key":"10917_CR91","doi-asserted-by":"publisher","first-page":"e0201858","DOI":"10.1371\/journal.pone.0201858","volume":"13","author":"MM Uddin","year":"2018","unstructured":"Uddin MM, Zou Y, Sharma T et al (2018) Proteasome Inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: opportunity for combination therapy. PLoS ONE 13:e0201858. https:\/\/doi.org\/10.1371\/journal.pone.0201858","journal-title":"PLoS ONE"},{"key":"10917_CR92","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1158\/1541-7786.MCR-10-0368","volume":"9","author":"A Juvekar","year":"2011","unstructured":"Juvekar A, Manna S, Ramaswami S et al (2011) Bortezomib induces nuclear translocation of I\u03baB\u03b1 resulting in Gene-Specific suppression of NF-\u03baB\u2013Dependent transcription and induction of apoptosis in CTCL. Mol Cancer Res 9:183\u2013194. https:\/\/doi.org\/10.1158\/1541-7786.MCR-10-0368","journal-title":"Mol Cancer Res"},{"key":"10917_CR93","doi-asserted-by":"publisher","first-page":"70798","DOI":"10.18632\/oncotarget.19990","volume":"8","author":"HR Gatla","year":"2017","unstructured":"Gatla HR, Zou Y, Uddin MM, Vancurova I (2017) Epigenetic regulation of interleukin-8 expression by class I HDAC and CBP in ovarian cancer cells. Oncotarget 8:70798\u201370810. https:\/\/doi.org\/10.18632\/oncotarget.19990","journal-title":"Oncotarget"},{"key":"10917_CR94","doi-asserted-by":"publisher","first-page":"1155621","DOI":"10.3389\/fonc.2023.1155621","volume":"13","author":"M Matamala Montoya","year":"2023","unstructured":"Matamala Montoya M, van Slobbe GJJ, Chang J-C et al (2023) Metabolic changes underlying drug resistance in the multiple myeloma tumor microenvironment. Front Oncol 13:1155621. https:\/\/doi.org\/10.3389\/fonc.2023.1155621","journal-title":"Front Oncol"},{"key":"10917_CR95","doi-asserted-by":"publisher","first-page":"6037","DOI":"10.1038\/s41467-020-19932-1","volume":"11","author":"C Federico","year":"2020","unstructured":"Federico C, Alhallak K, Sun J et al (2020) Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma. Nat Commun 11:6037. https:\/\/doi.org\/10.1038\/s41467-020-19932-1","journal-title":"Nat Commun"},{"key":"10917_CR96","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00277-024-06163-3","volume":"104","author":"H Yu","year":"2025","unstructured":"Yu H, Wu C, He J et al (2025) Metabolic reprogramming induced by PSMA4 overexpression facilitates bortezomib resistance in multiple myeloma. Ann Hematol 104:1023\u20131037. https:\/\/doi.org\/10.1007\/s00277-024-06163-3","journal-title":"Ann Hematol"},{"key":"10917_CR97","doi-asserted-by":"publisher","first-page":"e33001","DOI":"10.1016\/j.heliyon.2024.e33001","volume":"10","author":"H Huang","year":"2024","unstructured":"Huang H, Chen Y, Li Y et al (2024) Cytidine triphosphate synthase 1-mediated metabolic reprogramming promotes proliferation and drug resistance in multiple myeloma. Heliyon 10:e33001. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33001","journal-title":"Heliyon"},{"key":"10917_CR98","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41420-025-02498-6","volume":"11","author":"M Jia","year":"2025","unstructured":"Jia M, Fu Z, Ye C et al (2025) Targeting MTHFD2 alters metabolic homeostasis and synergizes with bortezomib to inhibit multiple myeloma. Cell Death Discov 11:201. https:\/\/doi.org\/10.1038\/s41420-025-02498-6","journal-title":"Cell Death Discov"},{"key":"10917_CR99","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1002\/cam4.1596","volume":"7","author":"C Wu","year":"2018","unstructured":"Wu C, Yang T, Liu Y et al (2018) ARNT\/HIF-1\u03b2 links high-risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myelomamyeloma. Cancer Med 7:3899\u20133911. https:\/\/doi.org\/10.1002\/cam4.1596","journal-title":"Cancer Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10917-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10917-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10917-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T04:27:32Z","timestamp":1766896052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10917-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10917"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10917-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is a narrative review and does not need ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"804"}}